Hantz Financial Services’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7K Buy
+406
New +$6.07K ﹤0.01% 2167

Other funds holding SMMT

Hantz Financial Services's SMMT Position: Q3 2026 in Review

Hantz Financial Services opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 406 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #2167 among its holdings.

298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Hantz Financial Services held 406 shares of Summit Therapeutics worth $7K as of Q3 2026.
  • Summit Therapeutics was a new Hantz Financial Services position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Hantz Financial Services's portfolio in Q3 2026, its #2167 holding.
  • 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Hantz Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.